International Stem Cell CORP Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
International Stem Cell CORP quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • International Stem Cell CORP Return On Equity for the quarter ending September 30, 2024 was 16.4 %.
  • International Stem Cell CORP annual Return On Equity for 2023 was 3.21 %, a 56.2% decline from 2022.
  • International Stem Cell CORP annual Return On Equity for 2022 was 7.32 %, a 63.5% decline from 2021.
  • International Stem Cell CORP annual Return On Equity for 2021 was 20 %, a 73.1% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 3.21 -4.11 -56.2% Jan 1, 2023 Dec 31, 2023
2022 7.32 -12.7 -63.5% Jan 1, 2022 Dec 31, 2022
2021 20 -54.3 -73.1% Jan 1, 2021 Dec 31, 2021
2020 74.3 -216 -74.4% Jan 1, 2020 Dec 31, 2020
2019 291 +390 Jan 1, 2019 Dec 31, 2019
2018 -99.1 +492 +83.2% Jan 1, 2018 Dec 31, 2018
2017 -591 -634 -1464% Jan 1, 2017 Dec 31, 2017
2016 43.3 +377 Jan 1, 2016 Dec 31, 2016
2015 -334 -1.29K -135% Jan 1, 2015 Dec 31, 2015
2014 955 +526 +122% Jan 1, 2014 Dec 31, 2014
2013 429 +1.48K Jan 1, 2013 Dec 31, 2013
2012 -1.05K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.